The role of fibre-optic bronchoscopy in solid organ, transplant patients with pulmonary infections

Respiratory Medicine

Volumn 93, Issue 9, 1999, Pages 621-629

  Nusair, S ^a   Kramer, M R ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL PNEUMONIA; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; EARLY DIAGNOSIS; FIBEROPTIC BRONCHOSCOPY; HEART LUNG TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG INFECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MICROBIOLOGY; MYCOSIS; OPEN LUNG BIOPSY; ORGAN TRANSPLANTATION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; TRANSBRONCHIAL BIOPSY; VIRUS PNEUMONIA;

EID: 0032878393     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(99)90101-4     Document Type: Article

References (75)

1. Frattini JE, Trulock EP. Respiratory infections in immunocompromised patients. Immunol Allerg Clin N Am 1993; 13: 193-204.
2. Nicholson V, Johnson PC. Infectious complications in solid organ transplant recipients. Surg Clin N Am 1994; 74: 1223-1245.
3. Kramer MR, Marshall SE, Starnes VA, et al. Infectious complications in heart-lung transplantation. Arch Intern Med 1993; 153: 2010-2016.
4. Dummer JS. Infectious complications of transplantation. Cardiovasc Clin 1990; 20: 163-178.
5. Pisani RJ, Wright AJ. Clinical utility of bronchoalveolar lavage in immunocompromised hosts. Mayo Clin Proc 1992; 67: 221-227.
6. Cazzadori A, Di Perri G, Todeschini G, et al. Transbronchial biopsy in the diagnosis of pulmonary infiltrates in immunocompromised patients. Chest 1995; 107: 101-6.
7. Wallace RH, Kolbe J. Fiberoptic bronchoscopy and bronchoalveolar lavage in the investigation of the immunocompromised lung. N Z Med J 1992; 105: 215-217.
8. Sternberg RI, Baughman RP, Dohn MN, et al. Utility of bronchoalveolar lavage in assessing pneumonia in immunosuppressed renal transplant recipients. Am J Med 1993; 95: 358-364.
9. Ampel NM, Wing EJ. Legionella infection in transplant patients. Semin Respir Infect 1990; 5: 30-37.
10. Nampoory MR, Khan ZU, Johny KV, et al. Nocardiosis in renal transplant recipients in Kuwait. Nephrol Dial Transplant 1996; 11: 1134-8.
11. Arduino RC, Johnson PC, Miranda AG. Nocardiosis in renal transplant recipients undergoing immunosuppression with cyclosporine. Clin Infect Dis 1993; 16: 505-512.
12. Lewiston N, King V, Umetsu D, et al. Cystic fibrosis patients who have undergone heart-lung transplantation benefit from maxillary sinus antrostomy and repeated sinus lavage. Transplant Proc 1991; 23: 1207-1208.
13. Dummer JS, Montero CG, Griffith BP, et al. Infections in heart-lung transplant recipients. Transplantation 1986; 41: 725-729.
14. Dummer JS. Pneumocystis carinii infections in transplant recipients. Semin Respir infect 1990; 5: 50-57.
15. Winston DJ. Use of quinolone antimicrobial agents in immunocompromised patients. In: Hooper DC, Wolfson JS, eds. Quinolone Antimicrobial Agents. 2nd edn. Washington, DC: American Society for Microbiology, 1993; 435-471.
16. Losso IS, Breuer R, Or R, et al. Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study. Transplantation 1995; 60: 672-678.
17. Griffin JJ, Meduri GU. New approaches in the diagnosis of nosocomial pneumonia. Med Clin N Am 1994; 78: 1091-122.
18. Martin WJ, Smith TF, Brutinel WM, et al. Role of bronchoalveolar lavage in the assessment of opportunistic pulmonary infections: utility and complications. Mayo Clin Proc 1987; 62: 549-557.
19. Abramson MJ, Stone CA, Holmes PW, et al. The role of bronchoalveolar lavage in the diagnosis of suspected opportunistic pneumonia. Aust NZ J Med 1987; 17: 407-412.
20. Walker PA, White DA. Pulmonary disease. Med Clin N Am 1996; 80: 1137-1162.
21. Schulman LL, Smith CR, Drusin R, et al. Utility of airway endoscopy in the diagnosis of respiratory complications of cardiac transplantation. Chest 1988; 93: 960-967.
22. Baz M, Layish DT, Govert JA, et al. Diagnostic yield of bronchoscopies after isolated lung transplantation. Chest 1996; 110: 84-88.
23. Chan CC, Abi-Saleh WJ, Arroliga AC, et al. Diagnostic yield and therapeutic impact of flexible bronchoscopy in lung transplant recipients. J Heart Lung Transplant 1996; 15: 196-205.
24. Kramer MR, Stoer C, Lewiston NJ, et al. Trimethoprim-sulfamethoxazole prophylaxis for Pneumocystis carinii in heart-lung and lung transplantation. How effective and for how long ? Transplantation 1992; 53: 586-589.
25. Nathan SD, Ross DJ, Zakowski P, et al. Utility of inhaled pentamidine prophylaxis in lung transplant recipients. Chest 1994; 105: 417-20.
26. Schneider MM, Hoepelman AI, Eeftinck Schattenkerk JK, et al. A controlled trial of aerosolized pentamidine or trimethoprim-sulphamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia with human immunodeficiency virus infection. N Engl J Med 1992; 327: 1836-1841.
27. Broaddus C, Dake MD, Stulbarg MS, et al. Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the aquired immunodeficiency syndrome. Ann Intern Med 1985; 102: 747-752.
28. Shreeniwas R, Schulman LL, Berkman YM, et al. Opportunistic bronchopulmonary infections after lung transplantation: clinical and radiographic findings. Radiology 1996; 200: 349-356.
29. Jules-Elysee K, Stover DE, Zaman MB, et al. Aerosolized pentamidine: effect on diagnosis and presentation of Pneumocystis carinii pneumonia. Ann Intern Med 1990; 112: 750-757.
30. Soubani AO, Miller KB, Hassoun PM. Pulmonary complications of bone marrow transplantation. Chest 1996; 109: 1066-1077.
31. Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986; 153: 478-488.
32. Krischner J, Elfenbein G, Babington R, et al. Risk factors for cytomegalovirus pneumonia following allogeneic bone marrow transplantation after prophylaxis with intravenous immunoglobulin. Semin Hematol 1992; 29: 89-95.
33. Holland K, Wingard JR, Beschorner WE, et al. Bronchiolitis obliterans in bone marrow transplantation and its relationship to graft-versus-host disease and low IgG. Blood 1988; 72: 621-627.
34. Keenan RJ, Lega ME, Dummer JS, et al. Cytomegalovirus serologic status and postoperative infection correlates with risk of developing chronic rejection after pulmonary transplantation. Transplantation 1991; 51: 433-438.
35. Guilinger RA, Paradis IL, Dauber JH, et al. The importance of bronchoscopy with transbronchial biopsy and bronchoalveolar lavage in the management of lung transplant recipients. Am J Respir Crit Care Med 1995; 152: 2037-2043.
36. Dauber JH, Paradis IL, Duncan SR, Yousem SA. Pulmonary transplantation. In: Baughman RP, ed. Bronchoalveolar Lavage. St. Louis: Mosby Year Book, 1992: 64-89.
37. Sable CA, Donowitz GR. Infections in bone marrow transplant recipients. Clin Infect Dis 1994; 18: 273-284.
38. Slavin MA, Gooley TA, Bowden RA. Prediction of cytomegalovirus pneumonia after marrow transplantation from cellular characteristics and cytomegalovirus culture of bronchoalveolar lavage fluid. Transplantation 1994; 58: 915-919.
39. Egan JJ, Barber L, Lomax J, et al. Detection of human cytomegalovirus antigenemia; a rapid diagnostic technique for predicting cytomegalovirus infection/pneumonitis in lung and heart transplant recipients. Thorax 1995; 50: 9-13.
40. Van De Berg AP, Van Son WJ, Haagsma EB, et al. Prediction of recurrent cytomegalovirus disease after treatment with ganciclovir in solid-organ transplant recipients. Transplantation 1995; 55: 847-951.
41. Schulman LL, Reison DS, Austin JHM, et al. Cytomegalovirus pneumonitis after cardiac transplantaion. Arch Intern Med 1991; 151: 1118-1124.
42. Ettinger NA, Bailey TC, Trulock EP, et al. Cytomegalovirus pneumonitis: impact following isolated lung transpalntation. Am Rev Respir Dis 1993; 147: 1017-1023.
43. Crawford SW, Bowden RA, Hackamn RC, et al. Rapid detection of CMV pulmonary infection by bronchoalveolar lavage and centrifugation culture. Ann Intern Med 1988; 108: 180-185.
44. Gleaves CA, Smith TF, Shuster EA, et al. Comparison of standard tube and shell vial techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol. 1985; 21: 217-221.
45. Solans EP, Garrity ER, McCabe M, et, al. Early diagnosis of cytomegalovirus pneumonitis in lung transplant patients. Arch Pathol Lab 1995; 119: 33-35.
46. Chou S. Newer methods for diagnosis of cytomegalovirus infection. Rev Infect Dis 1990; 12: S727-S736.
47. Kramer MR, Denning DW, Marshall SE, et al. Ulcerative tracheobronchitis following lung transplantation: a new form of invasive aspergillosis. Am Rev Respir Dis 1991; 144: 552-556.
48. Chugh KS, Sakhuja V, Jain S, et al. Fungal infections in renal allograft recipients. Transplant Proc 1992; 24: 1940-1942.
49. Latif S, Saffarian N, Bellovich K, et al. Pulmonary mucomycosis in diabetic renal allograft recipients. Am J Kidney Dis 1997; 29: 461-464.
50. Kahn FW, Jones JM, England DM. The role of lavage in the diagnosis of invasive pulmonary aspergillosis. Am J Clin Pathol 1986; 86: 518-523.
51. von-Eiff M, Roos N, Fegeler W, et al. Pulmonary fungal infections in immunocompromised patients: incidence and risk factors. Mycoses 1994; 37: 329-335.
52. Sobonya R, Barbee RA, Wiens J, et al. Detection of fungi and other pathogens in immunocompromised patients by bronchoalveolar lavage in an area endemic for coccidioidomycosis. Chest 1990; 97: 1349-1355.
53. Saito H, Anaissie EJ, Morice RC, et al. Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemia. Chest 1988; 94: 745-749.
54. Delany V, Sumrani N, Hong JH, et al. Mycobacterial infections in renal allograft recipients. Transplant Proc 1993; 25: 2288-2889.
55. Sakhuja V, Jha V, Varma PP, et al. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation 1996; 61: 211-215.
56. John GT, Juneja R, Mukundan U, et al. Gastric aspiration of pulmonary tuberculosis in adult renal allograft recipients. Transplantation 1996; 61: 972-973.
57. Hall CM, Willcox PA, Swanepoel CR, et al. Mycobacterial infection in renal transplant recipients. Chest 1994; 106: 435-439.
58. Qunibi WY, al-Sibai MB, Taher S, et al Mycobacterial infection after renal transplantation - report of 14 cases and review of the literature. Q J Med 1990; 77: 1039-1060.
59. Kennedy DJ, Lewis WP, Barnes PF. Yield of bronchoscopy for the diagnosis of tuberculosis in patients with the human immunodeficiency virus infection. Chest 1992; 102: 1040-1044.
60. Anderson C, Inhaber N, Menzies D. Comparison of sputum induction with fiber-optic bronchoscopy in the diagnosis of tuberculosis. Am J Respir Crit Care Med 1995; 152: 1570-1574.
61. Daley CL, Mugusi F, Chen LL, et al. Pulmonary complications of HIV infection in Dar es Salaam, Tanzania. Role of bronchoscopy and bronchoalveolar lavage. Am J Respir Crit Care Med 1996; 154: 105-110.
62. Richeldi L, Barnini S, Saltini C. Molecular diagnosis of tuberculosis. Eur Respir J 1995; 8 Suppl. 20: 689S-700S.
63. American thoracic society workshop. Rapid diagnostic tests for tuberculosis. Am J Respir Crit Care Med 1997; 155: 1804-1814.
64. Walker WA, Cole FH Jr., Khandekar A, et al. Does open lung biopsy affect treatment in patients with diffuse pulmonary infiltrates? J Thorac Cardiovasc Surg 1989; 97: 534-540.
65. Kramer MR, Berkman N, Mintz B, et al. The role of open lung biopsy in the management and outcome of patients with diffuse lung diseases. Ann Thorac Surg 1998; 6: 198-202.
66. Chaparro C, Maurer JR, Chamberlain DW, et al. Role of open lung biopsy for diagnosis in in lung transplant recipients: ten-year experience. Ann Thorac Surg 1995; 59: 928-932.
67. Miller R, Burton NA, Karwande SV, et al. Early, aggressive open lung biopsy in heart transplant recipients. J Heart Transplant 1987; 6: 96-99.
68. Waltzer WC, Sterioff S, Zincke H, et al. Open-lung biopsy in the renal transplant recipient. Surgery 1980; 88: 601-610.
69. Haverkos HW, Dowling JN, Pasculle AW, et al. Diagnosis of pneumonitis in immunocompromised patients by open lung biopsy. Cancer 1983; 52: 1093-1097.
70. Leight GS Jr. Michaelis LL. Open lung biopsy diagnosis of acute, diffuse pulmonary infiltrates in the immunosuppressed patient. Chest 1978; 73: 477-82.
71. Chesun BD, Samlowski WE, Tang TT, et al. Value of open lung biopsy in 87 immunocompromised patients with pulmonary infiltrates. Cancer 1985; 55: 453-459.
72. Kusne S, Dummer JS, Ho M, et al. Infections after liver transplantation: an analysis of 101 consecutive cases. Medicine 1988; 67: 132-143.
73. Sibley RK, Berry GJ, Tazelaar HD, et al. The role of transbronchial biopsies in the management of lung transplant recipients. J Heart Lung Transplant 1993; 12: 308-324.
74. Willcox PA, Bateman ED, Potgieter PD, Benatar SR. Experience with fiberoptic bronchoscopy in the diagnosis of pulmonary shadows in renal transplant recipients over a 12-year period. Respir Med 1990; 84: 297-302.
75. Allen KA, Markin RS, Rennard SI, et al. Bronchoalveolar lavage in liver transplant patients. Acta Cytol 1989; 33: 539-543.